Who Gets to Heal? Meredith Thomas Questions Whether Psychedelic Access Should Require a Diagnosis

Most legal psychedelic access increasingly requires a diagnosis or documented suffering, even though people may seek these medicines for growth, creativity, spiritual connection, meaning, or greater presence rather than treatment of a recognized illness. Meredith Thomas, executive director of Thank You Life, contrasts the field's diagnostic gatekeeping with Oregon and Colorado's non-medical psilocybin access models and argues that financial need should not automatically be coupled with medical justification. Her nonprofit began funding care for people facing severe suffering and financial barriers, but a donor's gift for supported ayahuasca retreats at Soltara has prompted debate about whether assistance should also reach people without diagnoses. The discussion does not reject clinical psychedelic therapy or prioritization of acute need. Instead, it asks whether supporting personal growth can also produce public benefits and whether the emerging system can hold medical treatment and broader human flourishing together without reproducing the exclusions of conventional mental healthcare.